Robert Levy Memorial Lecture

2022 William Virgil Brown, MD
“Changing the Future of Heart Disease”

2021 Penny M. Kris-Etherton, PhD, FAHA
"The Virtues of a Healthy Lifestyle on Lipids, Lipoproteins and CVD"

2020 Neil J. Stone MD, FAHA
"The Clinician-Patient Risk Discussion: Personalizing Metabolic & Atherosclerotic Risk for Patients"

2019 Frank M. Sacks, MD, FAHA
"New human biology of HDL: connecting epidemiology and metabolism"

2018 Daniel J. Rader, MD, FAHA
"Genomic Medicine Meets Public Health in the Prevention of Cardiovascular Disease"

2017 Marja-Riitta Taskinen, MD, PhD
"Can Fatty Liver Cause a Broken Heart"

2016 Sekar Kathiresan, MD, FAHA
"Genetic Risk, Adherence To A Healthy Lifestyle, And Risk For Coronary Artery Disease"

2015 Alice H. Lichtenstein, DSc, FAHA
"Trans Fatty Acids: Falling Down the Rabbit Hole"

2014 Johannes J. P. Kastelein MD, PhD
"Familial Hypercholesterolemia – the journey from a lethal disorder to a manageable dyslipidemia"

2013 Henry Ginsberg MD, FAHA
"Regulation of Plasma Lipoprotein Levels in Humans: New Insights Using Methods Pioneered by Bob Levy"

2012 H. Bryan Brewer, Jr, MD
"HDL: A Novel Target or a Marker to Reducing Cardiovascular Risk"

2011 Allan R. Tall, MD, FAHA
"HDL and ABC Transporters Reduce the Proliferation of Hematopoietic Stem and Progenitor Cells, with Anti-atherogenic Consequences"

2010 B. Gregory Brown, MD, PhD, FAHA
"Measurement of Coronary Obstruction, Its Progression and Its Reversal"

2009 Jonathan Cohen, PhD
"LDL and Atherosclerosis: What Simple Genetics tell us about a Complex Disease"

2008 Robert Eckel, MD, FAHA
"Tissue Specific Regulation of Lipoprotein Lipase and Energy Balance: The Story Gets Even More Interesting"

2007 Ira Goldberg, MD, FAHA
"Triglyceride: Nutrient and Toxin"

2006 Steven Blair, PhD
"Physical Activity in the Prevention and Treatment of Cardiovascular Diseases"

2005 Barbara Howard, PhD, FAHA
"Diabetes, Inflammation and CVD – A Tale of Two Populations"

2004 Ronald M. Krauss, MD
"Genetic and Dietary Probes of Atherogenic Lipoprotein Metabolism"

2003 Scott Grundy, MD, PhD, FAHA
"Benefit Beyond LDL Lowering: The Metabolic Syndrome as a Target for Clinical Intervention"

2002 Jan L. Breslow, MD, FAHA
"Genomic Approaches to Atherosclerosis Susceptibility"

2001 Antonio M. Gotto, Jr., MD, DPhil
"A 21st Century Perspective on Lipid Metabolism: Where have we been? Where are we going?"